EP0591395A4 - - Google Patents
Info
- Publication number
- EP0591395A4 EP0591395A4 EP19920914351 EP92914351A EP0591395A4 EP 0591395 A4 EP0591395 A4 EP 0591395A4 EP 19920914351 EP19920914351 EP 19920914351 EP 92914351 A EP92914351 A EP 92914351A EP 0591395 A4 EP0591395 A4 EP 0591395A4
- Authority
- EP
- European Patent Office
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US721723 | 1985-04-10 | ||
| US72172391A | 1991-06-26 | 1991-06-26 | |
| US75080191A | 1991-08-27 | 1991-08-27 | |
| PCT/US1992/005377 WO1993000075A1 (en) | 1991-06-26 | 1992-06-25 | Methods and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron |
| US750801 | 2000-12-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0591395A1 EP0591395A1 (en) | 1994-04-13 |
| EP0591395A4 true EP0591395A4 (US20040232935A1-20041125-M00001.png) | 1994-08-31 |
Family
ID=27110471
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP92914351A Withdrawn EP0591395A1 (en) | 1991-06-26 | 1992-06-25 | Methods and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron |
Country Status (5)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0591434A4 (en) * | 1991-06-26 | 1994-09-14 | Sepracor Inc | Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
| CN1078465C (zh) * | 1996-10-10 | 2002-01-30 | 沈阳药科大学 | 一种含奥坦西酮的透皮吸收制剂 |
| WO2000051582A2 (en) | 1999-03-01 | 2000-09-08 | Sepracor Inc. | Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron |
| WO2003037313A2 (en) * | 2001-10-31 | 2003-05-08 | Recovery Pharmaceuticals, Inc. | Methods for the treatment of addiction |
| JP5004236B2 (ja) * | 2005-02-09 | 2012-08-22 | キッセイ薬品工業株式会社 | 口腔内崩壊錠 |
| US20110288115A1 (en) * | 2010-05-24 | 2011-11-24 | Avmedis Llc | Treatment of vagally-mediated spectrum disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4695578A (en) * | 1984-01-25 | 1987-09-22 | Glaxo Group Limited | 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances |
| GB8516083D0 (en) * | 1985-06-25 | 1985-07-31 | Glaxo Group Ltd | Heterocyclic compounds |
| GB8518745D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Heterocyclic compounds |
| IE60991B1 (en) * | 1986-12-17 | 1994-09-07 | Glaxo Group Ltd | Use of ketone derivatives in the treatment of cognitive disorders |
-
1992
- 1992-06-25 AU AU22546/92A patent/AU2254692A/en not_active Abandoned
- 1992-06-25 WO PCT/US1992/005377 patent/WO1993000075A1/en not_active Application Discontinuation
- 1992-06-25 CA CA002112488A patent/CA2112488A1/en not_active Abandoned
- 1992-06-25 EP EP92914351A patent/EP0591395A1/en not_active Withdrawn
- 1992-06-25 JP JP5501665A patent/JPH06509073A/ja active Pending
Non-Patent Citations (3)
| Title |
|---|
| A.BUTLER ET AL.: "Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors", BR.J.PHARMACOL., vol. 94, 1988, pages 397 - 412 * |
| A.BUTLER ET AL.: "The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea -pig tissues", BR.J.PHARMACOL., vol. 101, 1990, pages 591 - 598 * |
| See also references of WO9300075A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1993000075A1 (en) | 1993-01-07 |
| CA2112488A1 (en) | 1993-01-07 |
| AU2254692A (en) | 1993-01-25 |
| JPH06509073A (ja) | 1994-10-13 |
| EP0591395A1 (en) | 1994-04-13 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19940111 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE |
|
| A4 | Supplementary search report drawn up and despatched | ||
| AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE |
|
| 17Q | First examination report despatched |
Effective date: 19950117 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 19960130 |